196 related articles for article (PubMed ID: 38646957)
1. Metabolite signature of human malignant thyroid tissue: A systematic review and meta-analysis.
Razavi SA; Khorsand B; Salehipour P; Hedayati M
Cancer Med; 2024 Apr; 13(8):e7184. PubMed ID: 38646957
[TBL] [Abstract][Full Text] [Related]
2. Metabolic changes associated with papillary thyroid carcinoma: A nuclear magnetic resonance-based metabolomics study.
Li Y; Chen M; Liu C; Xia Y; Xu B; Hu Y; Chen T; Shen M; Tang W
Int J Mol Med; 2018 May; 41(5):3006-3014. PubMed ID: 29484373
[TBL] [Abstract][Full Text] [Related]
3. Follicular adenomas exhibit a unique metabolic profile. ¹H NMR studies of thyroid lesions.
Deja S; Dawiskiba T; Balcerzak W; Orczyk-Pawiłowicz M; Głód M; Pawełka D; Młynarz P
PLoS One; 2013; 8(12):e84637. PubMed ID: 24376829
[TBL] [Abstract][Full Text] [Related]
4. The metabolomics and lipidomics window into thyroid cancer research.
Farrokhi Yekta R; Rezaie Tavirani M; Arefi Oskouie A; Mohajeri-Tehrani MR; Soroush AR
Biomarkers; 2017 Nov; 22(7):595-603. PubMed ID: 27805426
[TBL] [Abstract][Full Text] [Related]
5. Plasma metabolites analysis of patients with papillary thyroid cancer: A preliminary untargeted
Razavi SA; Mahmanzar M; Nobakht M Gh BF; Zamani Z; Nasiri S; Hedayati M
J Pharm Biomed Anal; 2024 Apr; 241():115946. PubMed ID: 38241910
[TBL] [Abstract][Full Text] [Related]
6. Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation.
Abooshahab R; Gholami M; Sanoie M; Azizi F; Hedayati M
Endocrine; 2019 Jul; 65(1):1-14. PubMed ID: 30937722
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach.
Lu J; Hu S; Miccoli P; Zeng Q; Liu S; Ran L; Hu C
Oncotarget; 2016 Dec; 7(49):81768-81777. PubMed ID: 27835583
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of post-surgical fine-needle aspiration biopsies of thyroid lesions with indeterminate cytology using HRMAS NMR-based metabolomics.
Rezig L; Servadio A; Torregrossa L; Miccoli P; Basolo F; Shintu L; Caldarelli S
Metabolomics; 2018 Oct; 14(10):141. PubMed ID: 30830426
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Shared and unique metabolic features of the malignant and benign thyroid lesions determined with use of
Skorupa A; Ciszek M; Chmielik E; Boguszewicz Ł; Oczko-Wojciechowska M; Kowalska M; Rusinek D; Tyszkiewicz T; Kluczewska-Gałka A; Czarniecka A; Jarząb B; Sokół M
Sci Rep; 2021 Jan; 11(1):1344. PubMed ID: 33446721
[TBL] [Abstract][Full Text] [Related]
11. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the metabolomic profile of renal cell carcinoma by high resolution magic angle spinning proton magnetic resonance spectroscopy.
Huynh MJ; Gusev A; Palmas F; Vandergrift L; Berker Y; Wu CL; Wu S; Cheng LL; Feldman AS
Urol Oncol; 2023 Nov; 41(11):459.e9-459.e16. PubMed ID: 37863744
[TBL] [Abstract][Full Text] [Related]
13.
Yi M; Dai X; Li Q; Zhao Y; Nie S; Wang D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):591-600. PubMed ID: 34275927
[TBL] [Abstract][Full Text] [Related]
14. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics as a potential method for predicting thyroid malignancy in children and adolescents.
Zhou Q; Zhang LY; Xie C; Zhang ML; Wang YJ; Liu GH
Pediatr Surg Int; 2020 Feb; 36(2):145-153. PubMed ID: 31576470
[TBL] [Abstract][Full Text] [Related]
16. Grading of endometrial cancer using
Skorupa A; Poński M; Ciszek M; Cichoń B; Klimek M; Witek A; Pakuło S; Boguszewicz Ł; Sokół M
Sci Rep; 2021 Sep; 11(1):18160. PubMed ID: 34518615
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic analysis of endometrial cancer by high-resolution magic angle spinning NMR spectroscopy.
Arda Düz S; Mumcu A; Doğan B; Yılmaz E; İnci Çoşkun E; Sarıdogan E; Tuncay G; Karaer A
Arch Gynecol Obstet; 2022 Dec; 306(6):2155-2166. PubMed ID: 35567635
[TBL] [Abstract][Full Text] [Related]
19. Toward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of study.
Torregrossa L; Shintu L; Nambiath Chandran J; Tintaru A; Ugolini C; Magalhães A; Basolo F; Miccoli P; Caldarelli S
J Proteome Res; 2012 Jun; 11(6):3317-25. PubMed ID: 22509853
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
